Virax Biolabs
VRAX
5 hedge funds and large institutions have $12.1K invested in Virax Biolabs in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.06% less ownership
Funds ownership: 0.09% → 0.03% (-0.06%)
79% less capital invested
Capital invested by funds: $57.1K → $12.1K (-$45K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$10.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.11K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$13 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$36K |
| 2 |
VF
Virtu Financial
New York
|
-$13K |
| 3 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$2.04K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
XT
1
XTX Topco
George Town,
Cayman Islands
| $7.41K | +$10.9K | +857 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $2.59K | +$2.11K | +166 | +124% |
|
|
3
National Bank of Canada
Montreal,
Quebec, Canada
| $2.07K | -$2.04K | -160 | -40% |
|
|
FFA
4
Farther Finance Advisors
San Francisco,
California
| $7 | – | – | – |
|
|
5
Osaic Holdings
Scottsdale,
Arizona
| $7 | +$13 | +1 | New |
|
6
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $3 | – | – | – |
|
|
HF
7
HRT Financial
New York
| – | -$36K | -2,403 | Closed |
|
|
VF
8
Virtu Financial
New York
| – | -$13K | -855 | Closed |
|
VRAX Hedge Fund Activity: Q4 2025 in Review
5 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Virax Biolabs (VRAX) for Q4 2025, worth a combined $12.1K — down 79% from $57.1K a quarter earlier.
Fund positioning in VRAX was balanced in Q4 2025: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was XTX Topco, opening a new position worth an estimated $10.9K. The largest seller was HRT Financial, exiting entirely with an estimated $36K sold.
- 5 institutional investors held Virax Biolabs (VRAX) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $12.1K of Virax Biolabs stock for Q4 2025, down 79% quarter-over-quarter.
- 2 funds opened new Virax Biolabs positions in Q4 2025 and 2 closed out, a net change of 0 holders.
- The largest Virax Biolabs buyer in Q4 2025 was XTX Topco, an estimated $10.9K added.
- The largest Virax Biolabs seller in Q4 2025 was HRT Financial, an estimated $36K sold.
Based on aggregated 13F filings for Q4 2025.